摘要:
A compressed powder product (60) intended for cosmetic use comprises at least one string of alphanumeric characters (24) displayed essentially throughout said usable thickness h and forming a message that is intended to inform the user of said product about at least one commercial, technical or regulatory characteristic of said product, said characters themselves consisting of a cosmetically acceptable substance, preferably also a compact powder, and being visually distinct from the rest of said product so that said message remains legible on the surface of said product during use, thereby implementing a method of informing the user about the cosmetic product.
摘要:
The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.
摘要翻译:所公开的物质恢复LOX和NRAGE蛋白之间的正常共表达和相互作用。 特别地,有效量的调节SEQ ID NO:1的LOX的表达和/或活性的物质和/或调节SEQ ID NO:2的NRAGE的表达和/或活性的物质可用于制造 用于调节LOX和NRAGE蛋白之间相互作用的组合物,以调节增殖,分化和凋亡的细胞现象之间的平衡,特别是在这些现象之间的平衡受到干扰的情况下,特别是在LOX和 NRAGE不存在或改变。 本发明可以特别地治疗和/或预防皮肤老化,扁平苔藓,移植物抗宿主反应(GVH),湿疹,牛皮癣和癌症,特别是上皮癌,特别是基底细胞或脊髓细胞的皮肤上皮癌 类型。
摘要:
The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation.
摘要:
The invention relates to methods useful in studying or modulating skin or hair pigmentation and to the use of plant extracts in compositions as well as to methods comprising the topical use of such compositions to reduce or to enhance skin or hair pigmentation.
摘要:
The disclosed substance restores normal co-expression and interaction between the LOX and NRAGE proteins. Particularly, an effective amount of the substance that modulates the expression and/or activity of LOX of SEQ ID NO: 1 and/or that modulates the expression and/or activity of NRAGE of SEQ ID NO: 2, may be used for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered. The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer of basocellular or spinocellular type.
摘要翻译:所公开的物质恢复LOX和NRAGE蛋白之间的正常共表达和相互作用。 特别地,有效量的调节SEQ ID NO:1的LOX的表达和/或活性的物质和/或调节SEQ ID NO:2的NRAGE的表达和/或活性的物质可用于制造 用于调节LOX和NRAGE蛋白之间相互作用的组合物,以调节增殖,分化和凋亡的细胞现象之间的平衡,特别是在这些现象之间的平衡受到干扰的情况下,特别是在LOX和 NRAGE不存在或改变。 本发明可以特别地治疗和/或预防皮肤老化,扁平苔藓,移植物抗宿主反应(GVH),湿疹,牛皮癣和癌症,特别是上皮癌,特别是基底细胞或脊髓细胞的皮肤上皮癌 类型。
摘要:
The invention relates to the use of a Rhodiola crenulata extract, via the topical route, for increasing the energy metabolism of the cutaneous tissues of a subject.The invention relates notably to topical compositions which comprise an active agent for increasing the energy metabolism of the cutaneous tissues of a subject, said active agent being a Rhodiola crenulata extract.The present invention enables making a cosmetic care such as: fighting against, or slowing down or preventing the loosening of the cutaneous tissue, increasing the plasticity of the cutaneous tissue, exerting an anti-wrinkle effect or slowing down or preventing the appearance of wrinkles, fighting against, slowing down or preventing the appearance of acne, exerting a depigmenting effect of the cutaneous tissue, in particular of the skin, and promoting desquamation of the cutaneous tissue (or “peeling”).
摘要:
This invention relates to the use of a preparation comprising sulfated oligosaccharides which trap spermine or spermidine or both, as an active slimming ingredient in a cosmetic, pharmaceutical and/or nutraceutical composition. One of the objectives of the invention is to supply a cosmetic, pharmaceutical or nutraceutical composition with a slimming effect.
摘要:
The invention relates to a substance for restoring normal co-expression and interaction between the LOX and NRAGE proteins.The invention relates in particular to the use of an effective amount of at least one substance that modulates the expression and/or activity of LOX of sequence ID no. 1, and/or that modulates the expression and/or activity of NRAGE of sequence ID no. 2, for the manufacture of a composition for modulating the interaction between the LOX and NRAGE proteins in order to regulate the balance between the cellular phenomena of proliferation, differentiation and apoptosis, particularly in cases where the balance between these phenomena is disturbed, and especially in cases where the interaction between LOX and NRAGE is absent or altered.The invention makes it possible especially to treat and/or prevent skin ageing, lichen planus, graft-versus-host reaction (GVH), eczema, psoriasis and a cancer, particularly an epithelial cancer and more particularly a cutaneous epithelial cancer, of basocellular or spinocellular type.
摘要:
The invention relates to plant extracts for stimulating the synthesis of hyaluronan synthase, particularly the synthesis of hyaluronan synthase 2 (HAS2). Specific aims of the invention are to increase firmness and/or elasticity and/or tissue moisturization, and/or increase the skin barrier effect, and/or increase tissue resilience, and/or modulate angiogenesis, or the neocreation of blood capillaries, and/or improve healing, and/or cell proliferation, migration or differentiation, and/or skin atrophy, and/or intended to combat the effects of ageing on the skin, and in particular to combat the loss of firmness of the skin observed in the course of ageing, and/or atrophied scars.
摘要:
The invention relates to the use of para-coumaric acid or para-hydroxycinnamic acid derivatives in cosmetic or dermatological compositions, specifically to the use of at least one compound derived from para-coumaric acid having a general formula (I) below: in which, especially, Z represents an oxygen or an —NH— group; X and Y are identical and each represent a CH or CH2 group, as an active principle with depigmenting, free-radical-scavenging and/or antiinflammatory activity. The invention also relates to the use of the above compounds for cosmetic care or for the preparation of a pharmaceutical composition, especially for depigmenting an area of skin, having antiradical and/or antiinflammatory activity.
摘要翻译:本发明涉及对香草酸或对羟基肉桂酸衍生物在化妆品或皮肤病学组合物中的用途,具体涉及使用至少一种衍生自下列通式(I)的对 - 香豆酸的化合物:其中, 特别地,Z表示氧或-NH-基团; X和Y是相同的,并且各自表示CH或CH 2 CO 2基团,作为具有脱色素,自由基清除和/或抗炎活性的活性成分。 本发明还涉及上述化合物用于化妆品护理或制备药物组合物,特别是用于脱色皮肤区域的具有抗原和/或抗炎活性的用途。